Free Trial

Conduit Pharmaceuticals (CDT) SEC Filings & 10K Form

→ Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad)
Free CDT Stock Alerts
$3.17
+0.07 (+2.26%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media

Recent Conduit Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/24/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Intelmed LLC (Reporting)
Lewis-Hall Freda C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Tapolczay David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
4:27 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
4:29 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
3:30 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form NT 10-K
02/12/2024
11:51 AM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Polar Asset Management Partners Inc. (Filed by)
Form SC 13G/A
02/08/2024
12:15 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13G/A
01/10/2024
3:43 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/18/2023
3:14 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
12/17/2023
11:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
12/14/2023
4:16 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Lewis-Hall Freda C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Sragovicz Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Tapolczay David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
McNealey Jennifer Isacoff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		Bligh James (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:50 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-1/A
12/01/2023
3:52 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/20/2023
7:37 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q/A
11/20/2023
4:29 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2023
3:49 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/05/2023
4:25 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K/A
10/02/2023
3:30 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
Form SC 13G
09/26/2023
4:37 PM		Algo Holdings, Inc. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Corvus Capital Ltd. (Reporting)
Regan Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/26/2023
4:41 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Intelmed LLC (Reporting)
Lewis-Hall Freda C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/26/2023
4:42 PM		Bligh James (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/26/2023
4:43 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
McNealey Jennifer Isacoff (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/26/2023
4:49 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
4:30 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Heilbron Jack Kendrick (Reporting)
Murphy Canyon Acquisition Sponsor, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
4:34 PM		Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/26/2023
4:34 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Tapolczay David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/22/2023
3:32 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form CERT
09/22/2023
3:33 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
09/22/2023
8:25 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-A12B
09/13/2023
12:53 PM		Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Conduit Pharmaceuticals (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
12:56 PM		Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Conduit Pharmaceuticals (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Form 425
09/13/2023
12:59 PM		Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Conduit Pharmaceuticals (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Form 424B3
09/07/2023
3:31 PM		Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Conduit Pharmaceuticals (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
3:31 PM		Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Conduit Pharmaceuticals (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Form 425
Exposed: 10 CENT Crypto to Explode April 20th? (Ad)

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024
08/31/2023
4:21 PM		Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Conduit Pharmaceuticals (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Form 425
08/23/2023
3:30 PM		Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Conduit Pharmaceuticals (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Form 424B3
08/23/2023
3:36 PM		Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Conduit Pharmaceuticals (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2023
3:39 PM		Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Conduit Pharmaceuticals (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Form 425
08/16/2023
7:30 AM		Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Conduit Pharmaceuticals (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
7:31 AM		Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Conduit Pharmaceuticals (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Form 425
08/14/2023
4:14 PM		Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Conduit Pharmaceuticals (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2023
11:15 PM		Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Conduit Pharmaceuticals (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Form EFFECT
07/21/2023
4:15 PM		Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Conduit Pharmaceuticals (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
4:15 PM		Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Conduit Pharmaceuticals (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Form 425
07/11/2023
3:35 PM		Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Conduit Pharmaceuticals (Filer)
Murphy Canyon Acquisition Corp. (Filer)
Form S-4/A
05/11/2023
3:31 PM		Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Conduit Pharmaceuticals (Subject)
Murphy Canyon Acquisition Corp. (Subject)
Form 425
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:CDT) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Why Big Pharma is Investing Billions in This Biotech
Behind the Markets
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace
The only accurate crypto trading system I know …
Weiss Ratings